Evaluation
*
LowBelow AvgAvgAbove AvgHigh
Faculty: Jennifer Robinson
Format
Cases
Program materials
Level of interaction
*
Strongly DisagreeDisagreeNeutralAgreeStrongly Agree
Discuss the emerging role of PCSK9 inhibition in preventive cardiology, specifically in patients at high risk for cardiovascular disease
Compare and contrast the efficacy/safety/tolerability profile data, mechanism of action, and administration of emerging PCSK9 inhibitors
Identify patients who have unmet cardiopreventive needs and who might benefit from novel, LDL-lowering therapeutic agents
*
Strongly DisagreeDisagreeNeutralAgreeStrongly Agree
This activity met my educational needs, expectations, and objectives
This activity was relevant to my practice
I feel confident treating patients in my practice based on this activity
This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months
There is a continuing need for education on this topic
The presentation was scientifically sound and free of commercial bias or influence
*
*
*
*
*